FSUE “Endopharm” imported “Ethosuximide” not registered in the Russian Federation for treatment of children with epilepsy
On December 6, 2021, FSUE "Moscow Endocrine Plant", subordinated to the Ministry of Industry and Trade of Russia, in pursuance of the order of the Government of the Russian Federation dated November 26, 2021 No. 3341-r, purchased and imported 5,000 packages of a drug not registered in the Russian Federation, corresponding to the international non-proprietary name (INN) “Ethosuximide” (trade name “Petnidan”, 250 mg capsules No. 100, Germany), intended for the provision of medical care to children with epileptic seizures.
“Children should receive medicine as soon as possible,” said Mikhail Mishustin, the Prime Minister of the Russian Federation, at a meeting with Deputy Prime Ministers on November 29, 2021.
The drug with INN ethosuximide belongs to the pharmacotherapeutic group of antiepileptic drugs. The indications for the use of the drug are:
- pycnoleptic absences, as well as complex and atypical convulsive seizures;
- myoclonic-astatic small seizures (petit mal);
- juvenile myoclonic seizures (impulsive petit mal).
The legal mechanism created by the Government of Russia, the operational interaction of executive authorities, as well as the experience of FSUE Endopharm in the purchase and import of unregistered drugs, made it possible to fully purchase and import the drug with INN ethosuximide necessary for the treatment of children to the Russian Federation in time, not exceeding 1 week.
On December 7, 2021, the imported batch of the medicinal product was transferred to Pharmimex JSC for delivery to medical institutions in 82 constituent entities of the Russian Federation, determined by the Russian Ministry of Health.
It should be noted that the purchase and activities for the import and delivery of the Petnidan drug were financed by Pharmimex JSC.
FSUE “Endopharm” Imported “Ethosuximide” Not Registered in the Russian Federation for Treatment of Children with Epilepsy
8 December 2021
Comment type is not specified in the component properties.